News & Announcements

School research into health, disease, and medicine earned the most NIH research dollars of any U.S. pharmacy school—for the 40th consecutive year.

Ku earned his PhD this spring in Pharmaceutical Sciences and Pharmacogenomics (PSPG) from UC San Francisco.

The 2019 Mary Anne Koda-Kimble Seed Award for Innovation will fund nine bold research projects, ranging from studies of the molecular underpinnings of cancer to focus groups designed to prepare PharmD students for experiential learning.

Among all U.S. pharmacy schools, the UCSF School of Pharmacy earned the most research funding from the National Institutes of Health in 2018, totaling nearly $29 million dollars that will support studies spanning the basic to the clinical sciences.

Tuberculosis is usually treated with a six month regimen of daily antibiotics, but millions of patients do not recover from the disease during treatment. Rada Savic’s team showed that adjusting the duration of this regimen based on disease severity could lead to better outcomes.

UCSF’s Quantitative Biosciences Institute (QBI), founded two years ago, is making waves with its unique approach to scientific collaboration, catalyzing discoveries from cancer to psychiatry while supporting female scientists and engaging with the public.

Low-cost drug treatments can cure TB and malaria. Why, then, do these diseases claim so many lives?

Andrej Sali, PhD, has been elected as a member of the 2018 class of the National Academy of Sciences (NAS).

New research promises to take the guesswork out of matching individual cancer cases to the most effective choices of chemotherapy.

A culture of discovery and collaboration among faculty carries potential to “completely shake up their fields of study.”

If DNA is the blueprint for every cell in the body, then proteins are the cell’s construction workers, forklifts, and building materials.

A new PharmD curriculum; Implementing new practice opportunities for pharmacists; PharmD students shine in state and national clinical pharmacy competitions; A pioneer in pharmacogenomics; The NIH streak lives on; Improving adverse event reporting and medication therapy protocols; Big-data to cut drug discovery time; Computational approaches target dopamine receptors; Researchers expose industry manipulation of science by sugar industry; Women in science; more.